These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27498672)

  • 1. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
    Li Y; Nie Y; Tu S; Wang H; Zhou Y; Du Y; Cao J; Ye M
    Oncol Rep; 2016 Oct; 36(4):2108-16. PubMed ID: 27498672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
    Zhang Q; Feng Y; Liu P; Yang J
    Tumour Biol; 2017 Jul; 39(7):1010428317711312. PubMed ID: 28718369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
    Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
    Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
    Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
    Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.
    Zhang H; Sun Z; Li Y; Fan D; Jiang H
    Biomed Pharmacother; 2017 Apr; 88():285-292. PubMed ID: 28113080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
    Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
    PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
    Zhang C; Zou Y; Dai DQ
    Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis.
    Cui H; Zhao C; Gong P; Wang L; Wu H; Zhang K; Zhou R; Wang L; Zhang T; Zhong S; Fan H
    Sci Rep; 2015 Sep; 5():13781. PubMed ID: 26350239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
    Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
    Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
    Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
    J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.
    Yang Z; Wang R; Zhang T; Dong X
    Int J Clin Exp Pathol; 2015; 8(8):8869-80. PubMed ID: 26464628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.
    Lei H; Zou D; Li Z; Luo M; Dong L; Wang B; Yin H; Ma Y; Liu C; Wang F; Zhang J; Yu J; Li Y
    PLoS One; 2013; 8(4):e60369. PubMed ID: 23637748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer.
    Geng G; Liu X; Xu A; Lu Z; Chen K; He J; Qi D; Yuan X
    J Gene Med; 2020 May; 22(5):e3166. PubMed ID: 31984574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
    Zhang Z; Dai DQ
    World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
    Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
    Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
    Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.